- Rating
- 3
- Confidence
- 2
- Informativeness
- 2
- Presentation
- 1
- Soundness
- 2
Read review
Paper summary
This paper proposes HYBRIDGE, a hybrid sampler for receptor-guided joint sequence–structure generation of cyclic peptides. A receptor-free reference model supplies peptide variation, while a shared receptor potential guides backbone motion and residue substitutions under compiled covalent constraints. The potential is trained using crossed peptide–receptor panels and chemical supervision. On 103 held-out receptor components, HYBRIDGE achieves 61.2% H2T structural delivery, gaining 15.1 percentage points over execution without the learned potential and 5.6 over terminal-only use.
Critical strengths
- Constraint preservation throughout generation. HYBRIDGE explicitly preserves compiled covalent constraints during both backbone updates and residue substitutions, allowing receptor guidance to act on cyclic candidates throughout sampling.
- Controlled evidence for guidance during sampling. With the model, initialization, placement, seeds, and output slots fixed, guided generation improves structural delivery by 5.6 percentage points over terminal-only scoring and 15.1 points over disabling the learned potential. These comparisons directly support the benefit of adapting candidates before selection.
- Pair-specific receptor modeling. Crossed peptide-receptor comparisons cancel additive partner-specific score offsets. Chemistry counterfactuals and receptor-swap controls provide complementary evidence that the learned potential captures pairing preferences and drives receptor-dependent changes.
- Detailed and transparent evaluation. The paper reports component-level held-out evaluation, confidence intervals, failure-stage accounting, and path-validity controls. Including missing and invalid outputs in the denominator makes the delivery metric informative about practical generation reliability.
Critical weaknesses
- Cross-method comparisons are difficult to interpret. The methods use different native sampling budgets, and much of HYBRIDGE’s delivery advantage arises before interface evaluation, from successful backbone construction and certification. This supports pipeline reliability, but provides less direct evidence of superior receptor-specific design under comparable computational resources.
- Limited validation of binding quality. Structural delivery measures geometric validity, contact, and severe-overlap avoidance rather than affinity or specificity. The independent AF3 analysis covers only seven reciprocal receptor pairs, and the improvement over terminal-only scoring has a confidence interval that includes zero. Short molecular dynamics trajectories provide limited additional evidence.
- Unclear exploration beyond source scaffolds. Generation starts from perturbed training-bank backbones and preserves source-derived geometric targets along each path. The paper does not sufficiently quantify how this dependence affects conformational diversity, scaffold novelty, or coverage of structures unavailable in the source bank.
Questions for authors
- How do runtime and computational cost compare across methods? Could you report results under matched budgets and show whether the advantage persists when receptor-interface quality is evaluated conditional on successful backbone construction?
- How similar are generated peptides to their source scaffolds and nearest training examples, in both sequence and cyclic-aligned structure? How sensitive are delivery and diversity to source-bank size and composition?
- Could you report sensitivity to the potential scale β, guidance activation time, and sampling budget to assess the robustness of the structural delivery gains?
6 comments
[2/3] Response to Critical Weaknesses 2 and 3: Binding-Related Quality, AF3 Coverage, and Backbone Diversity
Critical Weakness 2: Binding-Related Quality, AF3 Coverage, and Geometric Persistence
1. External Predicted Affinity, Stricter Steric Screening, and Pocket Specificity
Following your request for stronger validation, we added official PRODIGY v2.4.0/FreeSASA v2.2.1 predictions on intended complexes, stricter clash screening, and 11-pocket geometric controls under common preprocessing (all 515 slots; best-target medians select the lowest-ΔG delivered design per covered target; geometric specificity requires intended-pocket compatibility with 0/10 compatible controls).
| Metric | HYBRIDGE | CP-Composer | RFpeptides |
|---|---|---|---|
| Delivery at d_min ≥ 2.00 Å ↑ | 33.6% | 1.6% | 2.7% |
| Delivered + Kd ≤ 1 μM ↑ | 24.7% | 2.5% | 0.0% |
| Delivered + Kd ≤ 100 nM ↑ | 11.3% | 1.2% | 0.0% |
| Best-target median ΔG (kcal/mol) ↓ | −8.78 | −8.29 | −6.21 |
| Best-target median Kd (nM) ↓ | 365.7 | 830.5 | 27,740.0 |
| Geometric specificity (%) ↑ | 43.3% | 3.7% | 0.6% |
HYBRIDGE achieves the highest affinity-qualified yields and strongest best-target ΔG and Kd medians, complementing the buried-area, contact-coverage, and delivered CHARMM36 results under Critical Weakness 1 (Table 3, p. 8, lines 379–398; Tables 22–23, pp. 41–42, lines 2183–2224).
2. Common Independent AF3 Evaluation and Geometric Persistence
We ran common AF3 prediction across all 103 targets with designed peptide coordinates withheld. Valid cyclic designs pass the Canonical-L check. Chain-pair ipTM (AF3 peptide–receptor interface confidence) and RMSDs use the median across five AF3 predictions per design; reported percentages use all 515 registered slots. Backbone RMSD fits peptide N/Cα/C/O atoms, and pose RMSD fits receptor Cα atoms.
| Metric | HYBRIDGE | CP-Composer | RFpeptides |
|---|---|---|---|
| Canonical-L validity ↑ | 90.3% | 25.4% | 26.2% |
| Valid cyclic, ipTM ≥ 0.60 ↑ | 61.6% | 17.7% | 17.1% |
| Valid cyclic, ipTM ≥ 0.65 ↑ | 47.2% | 13.2% | 12.6% |
| Valid cyclic, ipTM ≥ 0.70 ↑ | 31.7% | 8.7% | 8.2% |
| Delivered + ipTM ≥ 0.65 ↑ | 33.6% | 2.3% | 1.6% |
| Backbone RMSD ≤ 2 Å ↑ | 28.5% | 7.6% | 6.2% |
| Pose RMSD ≤ 10 Å ↑ | 27.4% | 9.5% | 0.0% |
HYBRIDGE leads at every AF3 confidence cutoff, reaching 14.4× and 21.6× baseline yields on delivered + ipTM ≥ 0.65 alongside stronger backbone and pose agreement (Appendix I.4, pp. 42–43, lines 2257–2294; Table 25, p. 43, lines 2269–2282). Within HYBRIDGE, seven-pair AF3 estimates a +0.0130 guided-minus-terminal margin (95% CI [−0.0030, +0.0270], Table 21, p. 40, lines 2133–2145), paired with +5.6 points delivery gain across 515 slots (CI [+1.2, +10.1], Table 1, p. 6, lines 297–304). Topology trajectories measure covalent and geometric persistence over the simulated interval (Figure 6, p. 10, lines 486–505; Table 16, p. 31, lines 1621–1627).
Critical Weakness 3: Backbone and Sequence Diversity Beyond Source Scaffolds
Compiled support retains local bond lengths, modeled bond angles, the peptide-bond branch, and H2T closure while backbone torsions and residue identities adapt within those constraints.
| Measurement | HYBRIDGE |
|---|---|
| Median cyclic sequence identity vs. bank ↔ | 45.5% |
| Median cyclic Cα RMSD vs. bank ↔ | 0.93 Å |
| Exact cyclic training-sequence repeats ↓ | 0 |
| Mean distinct valid sequences / 24 slots ↑ | 21.7 |
Bank comparisons span 2,232 outputs, and diversity counts distinct ring-valid sequences across 24 slots per target (Appendix I.5, Table 26, p. 43, lines 2303–2317; Figure S15, p. 44, lines 2322–2347). Receptor swapping shifts guided backbones by median 2.08 Å vs. ~0.13 Å under controls (Figure 4f, p. 9, lines 432–459). In the 60-slot study, shrinking the source pool while keeping 64 donors/seed holds H2T validity and receptor support at 83.3% (0.99× median runtime, Table 27, p. 44, lines 2365–2375).
[3/3] Response to Questions 1, 2, and 3: Computational Cost, Training-Bank Comparison, and Sensitivity
Question 1: Runtime, Computational Cost, and Conditional Interface Quality
As detailed under Critical Weakness 1, complete resource totals are 35.01, 89.23, and 52.20 h for HYBRIDGE, CP-Composer, and RFpeptides. Estimated qualified yields are 43.19, 1.40, and 1.66 designs per resource-hour. All totals include required pipeline stages; CP-Composer follows its official OpenMM cyclization protocol. HYBRIDGE’s accounting includes 64 source previews shared across eight lineages per seed and eight terminal continuations per lineage. The timing corpus uses 2,472 attempts per method; resource-hours sum GPU-hours and additional cyclization CPU-hours (Appendix I.3, p. 42, lines 2226–2255; Table 24, p. 42, lines 2247–2255).
After successful Canonical-L construction, delivery is 67.7%, 19.8%, and 13.3%. Among delivered complexes, median BSA is 808.3, 800.3, and 299.6 Ų, contact coverage is 83.3%, 80.0%, and 23.2%, and CHARMM36 target Rank@1 is 78.7%, 69.2%, and 44.4%. These directly quantify the interface stage conditional on backbone construction and subsequent delivery (Table 3, p. 8, lines 379–398; Tables 22–23, pp. 41–42, lines 2183–2224). Resource-normalized output quantifies cross-method efficiency, while the paired HYBRIDGE guidance schedules test the learned contribution with common execution settings (Table 1, p. 6, lines 297–304).
Question 2: Source Similarity, Training-Bank Comparison, and Source-Bank Sensitivity
Donors match length and H2T topology, exclude the target receptor component, and include at most one template per donor component. Each seed samples 64 donors without replacement, followed by cyclic recutting, constrained coordinate perturbation, and sequence corruption. Local covalent targets are retained while torsions and residue identities adapt (Appendix I.5, pp. 43–44, lines 2295–2347).
As detailed under Critical Weakness 3, the 2,232-output training-bank comparison gives 45.5% median cyclic sequence identity, 0.93 Å median cyclic-aligned Cα RMSD, and zero exact cyclic sequence repeats. Output diversity averages 21.7 distinct ring-valid cyclic sequences per 24 registered outputs per receptor component (Appendix I.5 and Table 26, p. 43, lines 2303–2317; Figure S15, p. 44, lines 2322–2347).
The source-pool intervention retains approximately half of eligible components by component-ID hash, with a minimum of 64, and still samples 64 donors per seed. The length-6 pool changes from 94 to 64 components. Full and reduced pools both give 83.3% validity and receptor support, at relative runtimes 1.00× and 0.99×, on the paired 60-slot development panel (Table 27, p. 44, lines 2365–2375). This tests eligible-pool dependence with the sampled-donor count fixed.
Question 3: Sensitivity to Score Scale β, Guidance Activation Time, and Sampling Budget
We added a one-factor-at-a-time study on the same four development targets of lengths 6, 10, 13, and 15, three paired seeds, and first five registered slots per target–seed combination: 60 slots per setting. The baseline uses β = 7.1727, onset 0.50, eight particles, and 50 reference steps.
| Configuration | H2T validity ↑ | Receptor support ↑ | Relative median runtime ↓ |
|---|---|---|---|
| Baseline | 83.3% | 83.3% | 1.00× |
| Lower β (3.5863) | 83.3% | 83.3% | 1.03× |
| Later onset (0.76) | 83.3% | 83.3% | 0.92× |
| Reduced source bank | 83.3% | 83.3% | 0.99× |
| More particles (16) | 83.3% | 83.3% | 2.08× |
| More reference steps (100) | 91.7% | 91.7% | 1.66× |
HYBRIDGE retains both pass rates under the tested scale, onset, and source-pool changes. Increasing reference steps from 50 to 100 raises validity and receptor support by 8.3 percentage points at 1.66× median runtime. These results quantify robustness and the response to additional computation (Appendix I.6, p. 44, lines 2349–2375; Table 27, p. 44, lines 2365–2375).
Thank you for your questions; they helped us make computational accounting, conditional interface quality, source dependence, and sensitivity explicit.
[1/3] Response to Critical Weakness 1: Computational Cost, Conditional Interfaces, and Guidance Attribution
Thank you for recognizing constraint-preserving generation, the controlled guidance evidence, pairing-specific receptor modeling, and the evaluation’s transparency. Below we address Critical Weakness 1 with complete pipeline accounting, comparisons after valid-backbone construction, and matched guidance schedules; new material is marked in blue.
1. Complete Pipeline Cost and Resource-Normalized Output
The timing corpus contains 2,472 attempts per method. CP-Composer follows its official protocol, including 2.97 GPU-h plus 86.26 additional CPU-h for OpenMM cyclization; resource-hours sum GPU-hours and additional cyclization CPU-hours. Qualified yield applies each method’s delivery fraction from the common registered panel to its measured attempted throughput. HYBRIDGE’s complete cost includes its source previews and terminal continuations. These estimates quantify delivered-design output per unit of measured computation (Appendix I.3, p. 42, lines 2226–2255; Table 24, p. 42, lines 2247–2255).
On GPU consumption alone, HYBRIDGE uses 35.01 versus 52.20 GPU-h for RFpeptides, with 61.2% versus 3.5% delivery. At d_min ≥ 2 Å, estimated qualifying yields are 23.72 versus 12.93 designs/GPU-h for HYBRIDGE and CP-Composer, excluding CP-Composer’s additional CPU work. Across 24 outputs, topology-valid fractions are 90.3% versus 23.0% (Table 18, p. 33, lines 1729–1742).
2. Interface Formation After Valid-Backbone Construction
Conditional delivery uses each method’s valid Canonical-L backbones; the remaining rows summarize delivered complexes. HYBRIDGE retains higher interface delivery after backbone failures have been removed from the comparison. The broader interface engagement and higher intended-receptor energy ranking provide additional evidence at the interface stage (Table 3, p. 8, lines 379–398; Tables 22–23, pp. 41–42, lines 2183–2224).
3. Learned Guidance Within the Same Execution Framework
The reference checkpoint, initialization, placement, covalent support, seeds, and registered slots are shared. Each schedule uses the same source-preview and terminal-branching settings. Generation-time guidance yields 29 additional delivered designs, a 5.6-percentage-point gain over terminal-only scoring, with receptor-component-paired bootstrap 95% CI [+1.2, +10.1] percentage points. Intended-receptor Rank@1 over all registered slots also increases from 60.0% to 63.7% (Table 1, p. 6, lines 297–304; Table 29, p. 45, lines 2419–2429).
To address your readability feedback, Section 5 and Appendix I.8 now explain in plain language why receptor adaptation and ring preservation must be coupled, how the updates work, and which controls support them (p. 46, lines 2430–2467).
Together, the resource accounting measures computational efficiency, the conditional comparison examines performance after valid-backbone construction, and the matched HYBRIDGE schedules test receptor adaptation with the surrounding execution machinery held common.